Hendrick R Edward, Cole Elodia B, Pisano Etta D, Acharyya Suddhasatta, Marques Helga, Cohen Michael A, Jong Roberta A, Mawdsley Gordon E, Kanal Kalpana M, D'Orsi Carl J, Rebner Murray, Gatsonis Constantine
Lynn Sage Comprehensive Breast Ctr and Dept of Radiology, Feinberg School of Medicine, Northwestern Univ, Galter Pavilion, 13th Floor, 251 E Huron St, Chicago, IL 60611, USA.
Radiology. 2008 Apr;247(1):38-48. doi: 10.1148/radiol.2471070418.
To retrospectively compare the accuracy for cancer diagnosis of digital mammography with soft-copy interpretation with that of screen-film mammography for each digital equipment manufacturer, by using results of biopsy and follow-up as the reference standard.
The primary HIPAA-compliant Digital Mammographic Imaging Screening Trial (DMIST) was approved by the institutional review board of each study site, and informed consent was obtained. The approvals and consent included use of data for future HIPAA-compliant retrospective research. The American College of Radiology Imaging Network DMIST collected screening mammography studies performed by using both digital and screen-film mammography in 49 528 women (mean age, 54.6 years; range, 19-92 years). Digital mammography systems from four manufacturers (Fischer, Fuji, GE, and Hologic) were used. For each digital manufacturer, a cancer-enriched reader set of women screened with both digital and screen-film mammography in DMIST was constructed. Each reader set contained all cancer-containing studies known for each digital manufacturer at the time of reader set selection, together with a subset of negative and benign studies. For each reader set, six or 12 experienced radiologists attended two randomly ordered reading sessions 6 weeks apart. Each radiologist identified suspicious findings and rated suspicion of breast cancer in identified lesions by using a seven-point scale. Results were analyzed according to digital manufacturer by using areas under the receiver operating characteristic curve (AUCs), sensitivity, and specificity for soft-copy digital and screen-film mammography. Results for Hologic digital are not presented owing to the fact that few cancer cases were available. The implemented design provided 80% power to detect average AUC differences of 0.09, 0.08, and 0.06 for Fischer, Fuji, and GE, respectively.
No significant difference in AUC, sensitivity, or specificity was found between Fischer, Fuji, and GE soft-copy digital and screen-film mammography. Large reader variations occurred with each modality.
No statistically significant differences were found between soft-copy digital and screen-film mammography for Fischer, Fuji, and GE digital mammography equipment.
以活检及随访结果作为参考标准,回顾性比较各数字设备制造商的数字乳腺摄影软拷贝解读与屏-片乳腺摄影对癌症诊断的准确性。
最初符合健康保险流通与责任法案(HIPAA)的数字乳腺成像筛查试验(DMIST)获各研究地点的机构审查委员会批准,并取得了知情同意书。批准及同意事项包括将数据用于未来符合HIPAA的回顾性研究。美国放射学会影像网络DMIST收集了49528名女性(平均年龄54.6岁;范围19 - 92岁)使用数字乳腺摄影和屏-片乳腺摄影进行的筛查乳腺摄影研究。使用了来自四个制造商(菲舍尔、富士、通用电气和豪洛捷)的数字乳腺摄影系统。对于每个数字制造商,构建了一个在DMIST中同时接受数字和屏-片乳腺摄影筛查的富含癌症病例的读者集。每个读者集包含在选择读者集时每个数字制造商已知的所有含癌研究,以及一部分阴性和良性研究。对于每个读者集,六名或十二名经验丰富的放射科医生参加相隔6周的两次随机排序的读片会议。每位放射科医生识别可疑发现,并使用七点量表对已识别病变中乳腺癌的可疑程度进行评分。根据数字制造商,使用接收者操作特征曲线(AUC)下的面积、软拷贝数字乳腺摄影和屏-片乳腺摄影的敏感性及特异性对结果进行分析。由于可用的癌症病例较少,未展示豪洛捷数字乳腺摄影的结果。所实施的设计有80%的把握度分别检测出菲舍尔、富士和通用电气的平均AUC差异为0.09、0.08和0.06。
菲舍尔、富士和通用电气的软拷贝数字乳腺摄影与屏-片乳腺摄影在AUC、敏感性或特异性方面未发现显著差异。每种检查方式都存在较大的读者间差异。
对于菲舍尔、富士和通用电气的数字乳腺摄影设备,软拷贝数字乳腺摄影与屏-片乳腺摄影之间未发现统计学上的显著差异。